1. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021) Authors: Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz-Soto... Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: e2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗